Exchange underlies all IT efforts

The focus over the past month has been more on health IT and EHRs, not information exchange, but of course exchange underlies all other efforts.

“It’s just remarkable to look back at where we were four years ago and take stock as measured through these meetings how far we’ve come and the complexity of the policy issues we’ve had to consider to reach our goals,” reflected Farzad Mostashari, MD, ScM, national coordinator for health IT, during the July 9 Health IT Policy Committee meeting—the 50th meeting to date.

Looking to the future, Mostashari said there is much work ahead in pushing the boundaries of interoperability and exchange, enabling the coordination of care and “making sure we look and learn from data, to see what is working, learn of emerging trends and issues and where to adapt policies.”

With the “daunting tasks” ahead of handling interoperability issues and a cultural change in the practice of medicine, he said now is the time to “listen and adapt.”

Meanwhile, of 800 physician groups, 46 percent plan to join a health information exchange, according to a HIMSS Analytics industry report, “5th Annual U.S. Ambulatory EHR & Practice Management Study,” published by CapSite.

Overall, the industry report examines views on market adoption, market share, market opportunity and vendor mind share across the physician market while incorporating HIMSS Analytics data for a larger picture of the ambulatory EHR and practice management marketplace, according to a release.

What has been your experience with information exchange? Is your organization benefiting from information exchange yet? Please share your experience.

 

Beth Walsh

Clinical Innovation + Technology editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.